A positive crossmatch in liver transplantation - No effect or inappropriate analysis? A prospective study

Transplantation

Volumn 64, Issue 1, 1997, Pages 54-59

  Hathaway, Mark ^a   Gunson, Bridget K ^a   Keogh, Adrian C ^a   Briggs, David ^b   Mcmaster, Paul ^a   Neuberger, James M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDROCORTISONE; LYMPHOCYTE ANTIBODY; TACROLIMUS;

ANTIBODY DETECTION; ARTICLE; FEMALE; GRAFT FAILURE; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LONG TERM CARE; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; TISSUE TYPING;

ADOLESCENT; ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; ANTILYMPHOCYTE SERUM; B-LYMPHOCYTES; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; LIVER TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; T-LYMPHOCYTES; TIME FACTORS;

EID: 0030789606     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00011     Document Type: Article

References (31)

1. Kirby RM, McMaster P, Clements D, et al. Orthotopic liver transplantation: post-operative complications and their management. Br J Surg 1987; 74: 3.
2. Pichlmayr R, Gubernatis G. Rejection of the liver and review of current immunosuppressive protocols. Transplant Proc 1987; 19: 4367.
3. Terasaki PI, Marchioro TL, Starzl TE. Serotyping of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In Russell OS, Winn HJ, Amos DB, eds. Histocompatibility testing. Washington, DC: National Academy of Science, National Research Council, 1965: 83.
4. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 622.
5. Ayres R, Adams D. Acute rejection of human liver allografts. In: Neuberger J, Adams D, eds. Immunology of liver transplantation. London: Edward Arnold, 1993: 197.
6. Iwatsuki S, Iwaki Y, Kano T, et al. Successful liver transplantation from crossmatch positive donors. Transplant Proc 1981; 13: 286.
7. Iwatsuki S, Rabin BS, Shaw BW Jr, et al. Liver transplantation against T cell positive warm crossmatches. Transplant Proc 1984; 16: 1427.
8. Takaya S, Duuesnoy R, Iwaki Y, et al. Positive crossmatch in primary human liver allografts under cyclosporine or FK506 therapy. Transplant Proc 1991; 23: 396.
9. Takaya S, Bronsther O, Iwaki Y, et al. The adverse impact on liver transplantation using positive crossmatch donors. Transplantation 1992; 53: 400.
10. Donaldson P, Thomson LJ, Heads A, et al. IgG donor-specific cross-matches are not associated with graft rejection or poor graft survival after liver transplantation. Transplantation 1995; 60: 1016.
11. Manez R, Kelly RH, Kobayashi M, et al. Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies towards further defining their significance. Hepatology 1995; 21: 1346.
12. Registry of the European Liver Transplant Association. Villejuif, France: Hospital Paul Brousse.
13. Ratner LL, Phelan D, Brunt EM, et al. Probable antibody-mediated failure of two ABO-compatible hepatic allografts in a single recipient. Transplantation 1993; 55: 814.
14. Hanto DW, Snover DC, Noreen HJ, et al. Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplant 1987; 1: 304.
15. Olseon PR, Weiblen RJ, O'Leary JJ, et al. A simple technique for inactivation of IgM antibodies. Vox Sang 1976; 30: 149.
16. Hubscher SG. Histological findings in liver allograft rejection: new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991; 18: 377.
17. Klintmalm GB, Olsen LM, Nery JR, et al. Treatment of hepatic artery thrombosis after liver transplantation with immediate vascular reconstruction: a report of three cases. Transplant Proc 1988; 20 (suppl 1): 610.
18. Langnas AN, Marujo W, Stratta RJ, et al. Hepatic allograft rescue following arterial thrombosis. Transplantation 1991; 51: 86.
19. Buckels JAC, Tisone G, Gunson BK, et al. Low hematocrit reduces hepatic artery thrombosis after liver transplantation. Transplant Proc 1989; 21: 3511.
20. Samuel D, Gillet D, Castaing D, et al. Portal and arterial thrombosis in liver transplantation: a frequent event in severe rejection. Transplant Proc 1989; 21: 2225.
21. Langnas AN, Marujo W, Stratta RJ, et al. Vascular complication after orthotopic liver transplantation. Am J Surg 1991; 161: 76.
22. Mor E, Schwartz ME, Sheiner PA, et al. Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation 1993; 56: 1399.
23. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705.
24. Batts KP, Moore SB, Perkins JD, et al. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988; 45: 376.
25. Lobo PI, Spencer C, Douglas MT, et al. The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation 1993; 55: 1063.
26. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome. Transplantation 1994; 54: 786.
27. Katz SM, Kimball PM, Ozaki C, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation 1994; 57: 610.
28. Ogura K, Koyama H, Takemoto S, et al. Significance of a positive crossmatch on outcome in human liver transplantation. Transplant Proc 1992; 24: 1465.
29. Talbot D, Bell A, Shenton BK, et al. The flow cytometric cross-match in liver transplantation. Transplantation 1995; 59: 737.
30. Demetris A, Nakamura K, Yagihashi A, et al. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 1992; 16: 671.
31. Van Hoek B, Wiesner RH, Ludwig J, Gores GJ, Moore B, Krom RA. Combination immunosuppression with azathioprine reduces the incidence of ductopenic and vanishing bile duct syndrome after liver transplantation. Transplant Proc 1991; 23: 1403.